60 results on '"Brinzolamide"'
Search Results
2. A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
3. Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)
4. Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt
5. Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt
6. To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes
7. To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes
8. 24-Hour Intraocular Pressure With Brinzolamide/Timolol Versus Brimonidine/Timolol
9. Brinzolamide-brimonidine Fixed Combination for Preventing IOP Elevation After Intravitreal Anti-VEGF Injections
10. Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes
11. The Effects of the Water Drinking Test on Intraocular Pressure
12. Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy
13. Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle Glaucoma
14. Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®
15. SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)
16. Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma
17. 24-hr Intraocular Pressure Control With SIMBRINZA ®
18. Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
19. Brinzolamide for the Treatment of Chronic Central Serous Chorioretinopathy
20. Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
21. Clinical Evaluation of Patients With X-linked Retinoschisis
22. Patient Preference Comparison of AZARGA Versus COSOPT in Patients With Glaucoma
23. Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension
24. Efficacy and Safety of Adding Azarga to Prostaglandin Monotherapy
25. A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
26. A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
27. Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension
28. A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
29. Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension
30. Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution
31. Earlier Intraocular Pressure Control After Ahmed Glaucoma Valve Implantation for Glaucoma
32. 6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension
33. Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular Hypertension
34. Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America
35. Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue
36. Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®
37. Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertension
38. Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH
39. Topical Brinzolamide Ophthalmic Suspension Versus Placebo in the Treatment of Infantile Nystagmus Syndrome
40. Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada
41. Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin Therapy
42. Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension
43. Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension
44. Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension
45. Patient Preference Comparison of AZARGA Versus COSOPT
46. A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin
47. Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil
48. A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%
49. Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination
50. Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.